Isatis is recognized by American research institutions
On March 27, 2009, Guangzhou Baiyunshan Hutchison Traditional Chinese Medicine Co., Ltd. and the National Institutes of Health signed a one-year cooperation agreement. Funding will be provided to study the antiviral mechanism of traditional Chinese medicine Isatis root. Isatis root became the first Chinese medicine research project funded by the National Institutes of Health. On March 26, the Global Antiviral Influenza Summit was held in the United States. As the world's largest health research institution, the National Institute of Health (NIH) invited top influenza virus experts from the United States, China, Japan, Sweden and other countries to discuss anti-influenza virus materials in Bethesda, Maryland. square.
Zhong Nanshan, academician of the Chinese Academy of Engineering and president of the Chinese Medical Association, gave a report on "Overview of Antiviral Combination Therapy in China". He pointed out that isatis root is a typical representative of antiviral traditional Chinese medicine. It has been used in China for more than 2,000 years and has good clinical effects. In vitro antiviral screening has basically confirmed its exact efficacy. It is reported that the "miraculous" effect of isatis root during the "SARS period" has made foreign experts have a strong research interest in its anti-viral mechanism.
Under the "matchmaking" of Academician Zhong Nanshan, my country's largest isatis root production company, Guangzhou Baiyunshan Hutchison Traditional Chinese Medicine, signed a cooperation agreement with the National Institutes of Health. The two parties have initially agreed that during the one-year cooperation, NIH will provide the world's advanced virus models to screen the antiviral effects of Baiyunshan Banlangen Granules, including influenza viruses, avian influenza viruses, SARS, hepatitis B virus, HIV, More than 20 highly pathogenic viruses including herpes zoster virus, and viruses with significant curative effects will be studied for in vivo experiments. According to the agreement, relevant scientific research funds will be funded by the NIH, making Baiyunshan Banlangen Granules the first traditional Chinese medicine product to receive NIH-funded research. Based on the NIH's research results, this product may be patentable and protected in the United States.
The research support initiated by the US NIH this time will help uncover the antiviral mechanisms of isatis root and other traditional Chinese medicines, and will be beneficial to international academic exchanges in the field of traditional Chinese medicine. In addition, given the authority of NIH and its influence on the U.S. FDA, the final research results may affect the direction of drug policies in European and American countries, and are of great significance to the internationalization of traditional Chinese medicine products.
An important obstacle for traditional Chinese medicine to go global is the access standards of European and American drugs. This time, the highest research institution in the United States funded the research on the traditional Chinese medicine isatis root, which is a milestone and marks the impact of American standards on the efficacy of Chinese traditional medicine. recognized.
In 2008, my country's total export volume of traditional Chinese medicine was only US$1.3 billion, which is still very small. There are 163 countries in the world that trade traditional Chinese medicines with China, including 154 exporting countries. Asia is still the export market for traditional Chinese medicine products, with a total amount of US$856 million. Europe ranked second, with exports totaling US$209 million.
It is understood that the international traditional medicine market is dominated by "foreign traditional Chinese medicine" produced in Japan and South Korea, because they provide quality inspection data that meets international standards, which is also missing in our country's traditional Chinese medicine.
The internationalization of traditional Chinese medicine may still have a long way to go. At present, it is necessary to promptly formulate quality inspection data related to traditional Chinese medicine that conforms to international standards and related international standards.
On August 16, 2009, the China-U.S. Economic Cooperation Conference was held in Changsha. Guests from the U.S. side included William Pitt, the former Vice Minister of Commerce and Chairman of the Global Alliance of Small and Medium Enterprises, and the former Governor of California, There were more than 20 people in the group including Hugh Greenwald. At this Sino-US Economic Cooperation Fair, Mr. Li Zhengchun, the leader of our company, was invited to participate. At the dinner hosted by the relevant departments of Hunan Province for American guests, the Chinese and American guests tasted isatis root herbal tea beverage together. The American guests spoke highly of Chinese herbal medicine for making such a pure-tasting specialty drink. The U.S. representative believes that Coca-Cola and Pepsi-Cola have dominated the beverage market in the United States for hundreds of years. These beverages are chemically synthesized carbonated drinks. There are essential differences between Chinese herbal tea drinks and carbonated drinks, and Chinese herbal tea drinks are still blank in the US market.
Therefore, the U.S. representative intends to introduce isatis root herbal tea to the country’s market.
After the meeting, the relevant leaders of the U.S. delegation proposed to Mr. Li Zhengchun that the U.S. would invest 50 million yuan to jointly build a Banlangen herbal tea production line in China, produce it in accordance with U.S. food safety requirements, and then supply it all to the U.S. market. , the cooperation is currently under negotiation.
Won the gold medal at the 4th China International Food Expo in 2009